262 related articles for article (PubMed ID: 9664176)
1. Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma.
González-Cámpora R; Galera-Ruiz D; Armas-Padrón JR; Otal-Salaverri C; Galera-Davidson H
Diagn Cytopathol; 1998 Jul; 19(1):4-8. PubMed ID: 9664176
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases.
Aratake Y; Kotani T; Tamura K; Araki Y; Kuribayashi T; Konoe K; Ohtaki S
Am J Clin Pathol; 1991 Sep; 96(3):306-10. PubMed ID: 1715126
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity].
Zoro P; Vassko V; Garcia S; Pazart L; Aho S; De Micco C
Ann Pathol; 1996 Sep; 16(4):261-5. PubMed ID: 9172614
[TBL] [Abstract][Full Text] [Related]
4. Nuclear grooves in the aspiration cytology of papillary carcinoma of the thyroid.
Rupp M; Ehya H
Acta Cytol; 1989; 33(1):21-6. PubMed ID: 2916367
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of COX-2 in thyroid nodules.
Kim SJ; Lee JH; Yoon JS; Mok JO; Kim YJ; Park HK; Kim CH; Byun DW; Suh KI; Yoo MH
Korean J Intern Med; 2003 Dec; 18(4):225-9. PubMed ID: 14717230
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical diagnosis of papillary thyroid carcinoma.
Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
[TBL] [Abstract][Full Text] [Related]
7. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
[TBL] [Abstract][Full Text] [Related]
8. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in "suspicious" thyroid cytology.
Lerma E; Mora J
Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
[TBL] [Abstract][Full Text] [Related]
10. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
Nasser SM; Pitman MB; Pilch BZ; Faquin WC
Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
[TBL] [Abstract][Full Text] [Related]
11. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ
Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HMFG2 and thyroglobulin in the diagnosis of thyroid fine needle aspiration (FNA).
Veneti S; Athanassiadou P; Kandaraki C; Kyrkou K
Cytopathology; 1997 Feb; 8(1):13-9. PubMed ID: 9068951
[TBL] [Abstract][Full Text] [Related]
13. Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid diseases.
Iwabuchi H; Toriya K; Mimura T; Tamai S; Ito K; Kato H
Acta Cytol; 1996; 40(2):158-63. PubMed ID: 8629391
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in benign and malignant thyroid tumors.
Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
[TBL] [Abstract][Full Text] [Related]
15. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of qualitative and quantitative variables in thyroid lesions.
Rout P; Shariff S
Cytopathology; 1999 Jun; 10(3):171-9. PubMed ID: 10390065
[TBL] [Abstract][Full Text] [Related]
17. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
18. Thyroid cancers. I. Papillary, follicular, and Hürthle cell.
Goldman ND; Coniglio JU; Falk SA
Otolaryngol Clin North Am; 1996 Aug; 29(4):593-609. PubMed ID: 8844732
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours.
Kotani T; Asada Y; Aratake Y; Umeki K; Yamamoto I; Tokudome R; Hirai K; Kuma K; Konoe K; Araki Y
J Pathol; 1992 Sep; 168(1):41-5. PubMed ID: 1360496
[TBL] [Abstract][Full Text] [Related]
20. The thyroid and parathyroid glands. CT and MR imaging and correlation with pathology and clinical findings.
Weber AL; Randolph G; Aksoy FG
Radiol Clin North Am; 2000 Sep; 38(5):1105-29. PubMed ID: 11054972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
